希慎(00014.HK)午後轉升2% 上半年基本溢利升1.2%派息平穩
希慎興業(00014.HK)今早(14日)平開後早市窄幅偏軟,中午公佈中期業績,上半年基本溢利升1.2%,中期息維持27仙。股價午後走高,最新報15.87元,轉升2.19%,成交210.93萬股,涉資3,277.44萬元。
集團上半年營業額17.3億元,按年升2.2%。純利7,500萬元,按年跌82.4%;每股盈利7仙。維持第一次中期息27仙。期內,經常性基本溢利及基本溢利均升1.2%至10.31億元。投資物業之公平值變動虧損由1.97億元增至9.64億元。
希慎指出,未來五年透過出售竹林苑部分資產,以及推動大埔林海山城及土瓜灣住宅項目的單位銷售,啓動80億元的資本循環計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.